EcoDrugPlus

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSMPUG00000005310
Gene Symbol: F2
4 Cross references
85 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSMPUG00000003357
Gene Symbol: F3
2 Cross references
243 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSMPUG00000010383
Gene Symbol: F7
2 Cross references
274 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSMPUG00000010244
Gene Symbol: F10
2 Cross references
237 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSMPUG00000010306
Gene Symbol: F11
2 Cross references
216 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSMPUG00000012028
Gene Symbol: F12
2 Cross references
185 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSMPUG00000011027
Gene Symbol: CCDC6
2 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSMPUG00000013999
Gene Symbol: CSF1R
2 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSMPUG00000016761
Gene Symbol: C1S
4 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSMPUG00000007615
Gene Symbol: C5
2 Cross references
208 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMPUG00000008214
Gene Symbol: CRHR1
2 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMPUG00000004567
Gene Symbol: CCND1
2 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).